SYQUANT CAPITAL SAS Quant / Systematic

CIK: 0001766392 · Show all filings

Period: Q1 2023 (← Previous) (Next →)

Filing Date: Apr 12, 2023

Total Value ($000): $43 (100.0% shares, 0.0% debt)

Holdings (7)

— HORIZON THERAPEUTICS PUB L 68.7%

Value ($000) $30 Shares 271,617 Est. Cost $0.11 Unrealized —

— MONEYGRAM INTL INC 10.8%

Value ($000) $5 Shares 448,200 Est. Cost $0.01 Unrealized —

— AMRYT PHARMA PLC 8.7%

Value ($000) $4 Shares 258,000 Est. Cost $0.01 Unrealized —

— APOLLO ENDOSURGERY INC 6.9%

Value ($000) $3 Shares 300,000 Est. Cost $0.01 Unrealized —

MANU MANCHESTER UTD PLC NEW 2.6%

Value ($000) $1 Shares 50,000 Est. Cost — Unrealized —

FTI TECHNIPFMC PLC 1.7%

Value ($000) $1 Shares 53,000 Est. Cost $8.02 Unrealized +65.8%

RACE FERRARI N V 0.6%

Value ($000) $0 Shares 1,010 Est. Cost $255.40 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	HORIZON THERAPEUTICS PUB L	271,617	$30	68.7%	$0.11	—	SHS	G46188101
—	MONEYGRAM INTL INC	448,200	$5	10.8%	$0.01	—	COM NEW	60935Y208
—	AMRYT PHARMA PLC	258,000	$4	8.7%	$0.01	—	SPONSORED ADS	03217L106
—	APOLLO ENDOSURGERY INC	300,000	$3	6.9%	$0.01	—	COM	03767D108
MANU	MANCHESTER UTD PLC NEW	50,000	$1	2.6%	—	—	Call	G5784H106
FTI	TECHNIPFMC PLC	53,000	$1	1.7%	$8.02	+65.8%	COM	G87110105
RACE	FERRARI N V	1,010	$0	0.6%	$255.40	0.0%	COM	N3167Y103